12 Most Undervalued Long-Term Stocks to Buy Right Now
On October 23, Gene Goldman, CIO at Cetera, joined CNBC television to discuss the market valuations and the sectors he thinks are undervalued.
Elevance Health Inc. (ELV)
Market is closed
Sector: Hospital & Medical Service Plans
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Hosking Partners Jeremy Hosking | 142,382 | $46,006,472 | +85% | 1.66% |
| 2. | Iridian Asset Management David Cohen And Harold Levy | 52,103 | $16,835,521 | +12% | 6.63% |
| 3. | Bayforest Capital Theodoros Tsagaris | 1,527 | $493,404 | +11% | 0.23% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $312.15 | 1,200 | $374,580.00 | 3,502 | 2025-08-19 | Filing | |
| $287.96 | 1,050 | $302,358.00 | 151,020 | 2025-07-18 | Filing | |
| $287.12 | 5,116 | $1,468,905.92 | 149,970 | 2025-07-18 | Filing | |
| $286.07 | 2,334 | $667,687.38 | 144,854 | 2025-07-18 | Filing | |
| $384.36 | 1,300 | $499,668.00 | 4,714 | 2021-07-23 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $424.82 | 4,588 | $1,949,074.16 | 18,977 | 2025-04-24 | Filing | |
| $415.13 | 443 | $183,902.59 | 1,847 | 2025-03-10 | Filing | |
| $396.30 | 3,504 | $1,388,635.20 | 10,116 | 2025-03-05 | Filing | |
| $432.14 | 7,417 | $3,205,182.38 | 8,423 | 2024-10-18 | Filing | |
| $531.52 | 753 | $400,234.56 | 8,744 | 2024-08-05 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 630,203 | $203,048,479 | 1.08% | |
| 2. | 454,075 | $146,720,719 | 0.32% | |
| 3. | 452,538 | $146,224,079 | 0.2% | |
| 4. | 389,399 | $125,822,605 | 1.8% | |
| 5. | 307,343 | $99,308,669 | 0.1% |
News See All
Elevance Health (ELV) Announces Fiscal Q3 2025 Results
Elevance Health, Inc. (NYSE:ELV) is one of the best long term low volatility stocks to buy right now. Elevance Health, Inc.
14 Best Long Term Low Volatility Stocks to Buy Right Now
Mike Wilson, Morgan Stanley CIO and chief U.S.
Cantor Fitzgerald Reaffirms Its Overweight rating and $400 Price Target on Elevance Health, Inc. (ELV)
As 2026 Marketplace rates were set, Cantor Fitzgerald reaffirmed its Overweight rating and $400 price target, drawing attention to Elevance Health, Inc. (NYSE:ELV) on September 16, 2025.
20 NYSE Stocks with the Lowest P/E Ratios
The S&P 500 has risen almost 13% so far this year and recorded 25 record closes in the last three months, as U.S. markets hovered close to record highs on September 25, 2025, according to Reuters.
Here's What Affected Elevance (ELV) in Q2
Artisan Partners, an investment management company, released its “Artisan Select Equity Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Elevance Health, Inc. (ELV) Reaffirms Full-Year 2025 Earnings Guidance
Elevance Health, Inc. (NYSE:ELV) announced on September 4, 2025, that it expects to reaffirm its full-year 2025 earnings guidance during upcoming investor meetings.
Elevance Health Reduces Medicare Footprint, Exits Standalone Part D Plans for Profitability
Elevance Health Inc. (NYSE:ELV) is one of the best inexpensive stocks to buy according to hedge funds.
10 Best Inexpensive Stocks to Buy According to Hedge Funds
On August 30, Ryan Detrick, Carson Group chief market strategist, joined 'Closing Bell' on CNBC and noted that we're in a bull market, but seasonal weakness wouldn't be shocking.
11 Best Roth IRA Stocks to Invest in Now
One of the most powerful tools available for long-term wealth creation is a Roth IRA.
Hedge Fund Resource Center Billionaire Hedge Funds
